Fortress Biotech (FBIO) Enterprise Value (2016 - 2025)
Fortress Biotech (FBIO) has 13 years of Enterprise Value data on record, last reported at -$76.9 million in Q3 2025.
- For Q3 2025, Enterprise Value rose 17.09% year-over-year to -$76.9 million; the TTM value through Sep 2025 reached -$76.9 million, up 17.09%, while the annual FY2024 figure was -$81.6 million, 19.87% up from the prior year.
- Enterprise Value reached -$76.9 million in Q3 2025 per FBIO's latest filing, up from -$80.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$76.9 million in Q3 2025 and bottomed at -$191.8 million in Q1 2022.
- Average Enterprise Value over 5 years is -$128.2 million, with a median of -$112.5 million recorded in 2023.
- Peak YoY movement for Enterprise Value: crashed 8315.29% in 2021, then skyrocketed 40.05% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$188.5 million in 2021, then increased by 9.85% to -$170.0 million in 2022, then surged by 40.05% to -$101.9 million in 2023, then increased by 19.87% to -$81.6 million in 2024, then grew by 5.82% to -$76.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$76.9 million in Q3 2025, -$80.9 million in Q2 2025, and -$81.1 million in Q1 2025.